Diamedica Therapeutics(DMAC)
$8.79-0.54 (-5.79%)
DMAC
Diamedica Therapeutics financials statements
$8.79
At close:-0.54 (-5.79%)
Want to see DMAC full AI Analyst Report?
Diamedica Therapeutics (DMAC) Income Statement
573 Followers
Diamedica Therapeutics Income Statement
Last quarter (Q3 2026), Diamedica Therapeutics's total revenue was $0.00. In Q3, Diamedica Therapeutics's net income was $-11.31M. See Diamedica Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 34.40M | $ 26.68M | $ 21.27M | $ 14.00M | $ 13.65M | |
| Depreciation and Amortization | $ 43.00K | $ 39.00K | $ 30.00K | $ 25.00K | $ 24.00K |
| $ -32.70M | $ -24.38M | $ -19.31M | $ -13.62M | $ -13.54M | |
| $ -34.40M | $ -26.68M | $ -21.27M | $ -14.00M | $ -13.65M | |
| $ 1.66M | $ 2.27M | $ 1.93M | $ 353.00K | $ 82.00K | |
| $ -32.74M | $ -24.41M | $ -19.34M | $ -13.65M | $ -13.56M | |
| $ -32.77M | $ -24.44M | $ -19.38M | $ -13.68M | $ -13.59M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.70 | $ -0.60 | $ -0.60 | $ -0.52 | $ -0.65 |
| Diluted EPS | $ -0.70 | $ -0.60 | $ -0.60 | $ -0.52 | $ -0.65 |
| Weighted Average Shares Outstanding | 46.98M | 40.40M | 32.57M | 26.44M | 20.77M |
| Weighted Average Shares Outstanding (Diluted) | 46.98M | 40.40M | 32.57M | 26.44M | 20.77M |
Currency in USD

